Serina Therapeutics Announces Publication of SER-214 (POZ-Rotigotine) Article in Journal of Movement Disorders By 100 Danish|2015-10-02T01:49:53+00:00October 30th, 2013|News|0 Comments Share This Story, Choose Your Platform! About the Author: 100 Danish Related Posts Serina Therapeutics Announces Publication of SER-214 Clinical Trial Results Serina Therapeutics Announces Publication of SER-214 Clinical Trial Results Dr. Randall Moreadith, President and CEO, will Present at Biotech Showcase During the Annual JP Morgan Healthcare Conference Dr. Randall Moreadith, President and CEO, will Present at Biotech Showcase During the Annual JP Morgan Healthcare Conference Serina Therapeutics Announces Dr. William K. Schmidt will Join the Clinical Advisory Board. Serina Therapeutics Announces Dr. William K. Schmidt will Join the Clinical Advisory Board. Serina Therapeutics Publishes Invited Manuscript on Tuning Drug Delivery Serina Therapeutics Publishes Invited Manuscript on Tuning Drug Delivery Serina Therapeutics Receives NIH Grant to Develop SER-227 for Post-Operative Pain Serina Therapeutics Receives NIH Grant to Develop SER-227 for Post-Operative Pain